8 results on '"Constance Michel"'
Search Results
2. Preparing for the Worst: Management and Predictive Factors of Open Conversion During Minimally Invasive Renal Tumor Surgery (UroCCR-135 Study)
- Author
-
Nicolas Branger, Nicolas Doumerc, Thibaut Waeckel, Pierre Bigot, Louis Surlemont, Sophie Knipper, Géraldine Pignot, François Audenet, Frank Bruyère, Alexis Fontenil, Bastien Parier, Cécile Champy, Morgan Rouprêt, Jean-Jacques Patard, François Henon, Gaëlle Fiard, Julien Guillotreau, Jean-Baptiste Beauval, Constance Michel, Simon Bernardeau, Fayek Taha, Richard Mallet, Frederic Panthier, Laurent Guy, Louis Vignot, Zine-Eddine Khene, and Jean-Christophe Bernhard
- Subjects
Renal cancer ,Open conversion ,Robot-assisted surgery ,Laparoscopic surgery ,Surgical complication ,Intraoperative complication ,Diseases of the genitourinary system. Urology ,RC870-923 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Background and objective: Data regarding open conversion (OC) during minimally invasive surgery (MIS) for renal tumors are reported from big databases, without precise description of the reason and management of OC. The objective of this study was to describe the rate, reasons, and perioperative outcomes of OC in a cohort of patients who underwent MIS for renal tumor initially. The secondary objective was to find the factors associated with OC. Methods: Between 2008 and 2022, of the 8566 patients included in the UroCCR project prospective database (NCT03293563), who underwent laparoscopic or robot-assisted minimally invasive partial (MIPN) or radical (MIRN) nephrectomy, 163 experienced OC. Each center was contacted to enlighten the context of OC: “emergency OC” implied an immediate life-threatening situation not reasonably manageable with MIS, otherwise “elective OC”. To evaluate the predictive factors of OC, a 2:1 paired cohort on the UroCCR database was used. Key findings and limitations: The incidence rate of OC was 1.9% for all cases of MIS, 2.9% for MIRN, and 1.4% for MIPN. OC procedures were mostly elective (82.2%). The main reason for OC was a failure to progress due to anatomical difficulties (42.9%). Five patients (3.1%) died within 90 d after surgery. Increased body mass index (BMI; odds ratio [OR]: 1.05, 95% confidence interval [CI]: 1.01–1.09, p = 0.009) and cT stage (OR: 2.22, 95% CI: 1.24–4.25, p = 0.008) were independent predictive factors of OC. Conclusions and clinical implications: In MIS for renal tumors, OC was a rare event (1.9%), caused by various situations, leading to impaired perioperative outcomes. Emergency OC occurred once every 300 procedures. Increased BMI and cT stage were independent predictive factors of OC. Patient summary: The incidence rate of open conversion (OC) in minimally invasive surgery for renal tumors is low. Only 20% of OC procedures occur in case of emergency, and others are caused by various situations. Increased body mass index and cT stage were independent predictive factors of OC.
- Published
- 2024
- Full Text
- View/download PDF
3. Concentric or eccentric physical activity for patients with symptomatic osteoarthritis of the knee: a randomized prospective study
- Author
-
Marie-Charlotte Trojani, Fréderic Chorin, Pauline Gerus, Véronique Breuil, Constance Michel, Sandrine Guis, David Bendahan, and Christian Roux
- Subjects
Diseases of the musculoskeletal system ,RC925-935 - Abstract
Background: Knee osteoarthritis–related pain limits physical function and leads to functional disability. Physical activity is one of the central recommendations for the management of knee osteoarthritis. Although concentric muscle activities are often preferred to eccentric ones, the corresponding rationale remains controversial. Objective: To explore the effect of a 6-week exercise program on function, pain, and performance in patients with symptomatic knee osteoarthritis. Methods: Patients with symptomatic knee osteoarthritis were included in the prospective EX-ART project (Walking performance in osteoARThritic subjects: effect of an ECCentric muscle strengthening program) and randomized in a 6-week rehabilitation program including either eccentric or concentric activities. Metrics of interest chosen as end points measured before and after the rehabilitation were WOMAC score, pain, and muscular performance (quadriceps power P MAX and contraction strength M MAX ). MRI was also used to assess muscle volume and fat infiltration changes. Results: 30 patients were included in each group; mean age was 74 (±7.6); 69% were women. At week 6, both groups showed a significant improvement in the WOMAC without difference between the two groups ( p = 0.7). No difference between the two groups was identified for the pain reduction ( p = 0.7). A significant improvement in the change in P MAX and M MAX at high velocity ( p = 0.001 and p = 0.002) was observed in the eccentric group only. A vastus medialis hypertrophy was quantified in the eccentric group only ( p = 0.002), whereas fat infiltration in the quadriceps muscles was unchanged. Conclusion: Physical activity, whether eccentric or concentric, has a benefit on function and pain in patients with symptomatic knee osteoarthritis. A few differences have been identified between the two types of rehabilitation. More particularly, a gain in muscle performance and vastus medialis volume was found with eccentric rehabilitation only. Registration: www.ClinicalTrials.gov , registration number NCT03167502.
- Published
- 2022
- Full Text
- View/download PDF
4. Ultra high field MRI (150 micron) assessment of the structural elements of the knee entheses in healthy subjects
- Author
-
Damien Roche, Constance Michel, Pierre Daudé, Arnaud Le Troter, Christophe Chagnaud, Jean-Pierre Mattei, Lauriane Pini, Maxime Guye, David Bendahan, and Sandrine Guis
- Subjects
Diseases of the musculoskeletal system ,RC925-935 - Published
- 2020
- Full Text
- View/download PDF
5. In vivo muscle function and energetics in women with sickle cell anemia or trait: a
- Author
-
Benjamin, Chatel, Emmanuelle, Bernit, Christophe, Vilmen, Constance, Michel, David, Bendahan, and Laurent A, Messonnier
- Subjects
Magnetic Resonance Spectroscopy ,Phosphocreatine ,Humans ,Anemia, Sickle Cell ,Muscle, Skeletal ,Sickle Cell Trait - Abstract
Sickle cell anemia (SCA) is a genetic hemoglobinopathy associated with an impaired oxygen delivery to skeletal muscle that could alter ATP production processes and increase intramuscular acidosis. These alterations have been already reported in the Townes mouse model of SCA but the corresponding changes in humans have not been documented. In the present study, we used 31-phosphorus magnetic resonance spectroscopy to investigate in vivo the metabolic changes induced by a moderate-intensity exercise in twelve SCA patients, eight sickle cell trait (SCT) carriers, and twelve controls women. The rest-exercise-recovery protocol disclosed slight differences regarding phosphocreatine (PCr) consumption and lactate accumulation between SCA patients and controls but these differences did not reach a statistical significance. On that basis, the in vivo metabolic changes associated with a moderate-intensity muscle exercise were slightly altered in SCA patients and SCT carriers but within a normal range. The present results strongly support the fact that a moderate-intensity exercise is safe and could be recommended in stable SCA patients and SCT subjects.
- Published
- 2020
6. Is it useful to combine taxanes with targeted agents in mCRPC patients—have we hit the target in this phase II study with docetaxel and curcumin allowing going for a phase III study?
- Author
-
Elise Nassif, Constance Michel, Constance Thibault, and Stéphane Oudard
- Subjects
Cancer Research ,Oncology ,Radiology, Nuclear Medicine and imaging - Published
- 2016
- Full Text
- View/download PDF
7. Long-term use of sunitinib in metastatic renal cell carcinoma: no unpleasant surprises about tolerability
- Author
-
Constance Michel, Constance Thibault, and Stephane Oudard
- Subjects
Cancer Research ,Oncology ,Radiology, Nuclear Medicine and imaging - Published
- 2016
- Full Text
- View/download PDF
8. Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer
- Author
-
Katherine Smith, Constance Michel, Thomas Powles, Shah-Jalal Sarker, Simon J. Crabb, Andrew Protheroe, Andrew Stockdale, Ekaterini Boleti, Mark Sullivan, Tim O'Brien, Giorgia Trevisan, Daniel C Worth, Grenville Oades, Charlotte Ackerman, Michael Aitchison, John Peters, Luis Beltran, Akhila Wimalasingham, Naveed Sarwar, Simon Chowdhury, Robert Jones, Elizabeth Harvey-Jones, and Anju Sahdev
- Subjects
Male ,Cancer Research ,medicine.medical_specialty ,Indazoles ,medicine.medical_treatment ,030232 urology & nephrology ,Angiogenesis Inhibitors ,Kaplan-Meier Estimate ,Nephrectomy ,Disease-Free Survival ,Pazopanib ,03 medical and health sciences ,0302 clinical medicine ,Interquartile range ,medicine ,Humans ,Progression-free survival ,Carcinoma, Renal Cell ,Aged ,Proportional Hazards Models ,Sulfonamides ,business.industry ,Cytoreduction Surgical Procedures ,Middle Aged ,medicine.disease ,Debulking ,Kidney Neoplasms ,Neoadjuvant Therapy ,Surgery ,Clear cell renal cell carcinoma ,Pyrimidines ,Treatment Outcome ,Oncology ,Chemotherapy, Adjuvant ,Response Evaluation Criteria in Solid Tumors ,030220 oncology & carcinogenesis ,Female ,business ,Progressive disease ,medicine.drug - Abstract
ImportanceThe role of cytoreductive nephrectomy in patients with metastatic renal cancer in the era of targeted therapy is uncertain.ObjectiveTo establish the safety and efficacy of upfront pazopanib therapy prior to cytoreductive nephrectomy in previously untreated patients with metastatic clear cell renal cancer.Design, Setting, and ParticipantsSingle-arm phase 2 study of 104 previously untreated patients with metastatic clear cell renal cancer recruited between June 2008 and October 2012 at cancer treatment centers with access to nephrectomy services. The minimum follow-up was 30 months.InterventionsPatients received 12 to 14 weeks of preoperative pazopanib therapy prior to planned cytoreductive nephrectomy and continued pazopanib therapy after surgery. Treatment was stopped at disease progression.Main Outcomes and MeasuresThe primary end point was clinical benefit (using Response Evaluation Criteria in Solid Tumors, version 1.1) prior to surgery (at 12-14 weeks). Secondary end points included surgical complications, progression-free survival (PFS), overall survival (OS), and biomarker analysis.ResultsOf 104 patients recruited, 100 patients were assessable for clinical benefit prior to planned nephrectomy; 80 of 104 (76.9%) were men; median [interquartile range] age, 64 [56-71] years). Overall, 84 of 100 (84% [95% CI, 75%-91%]) gained clinical benefit before planned nephrectomy. The median reduction in the size of the primary tumor was 14.4% (interquartile range, 1.4%-21.1%). No patients were unable to undergo surgery as a result of local progression of disease. Nephrectomy was performed in 63 (61%) of patients; 14 (22%) reported surgical complications. The 2 most common reasons for not undergoing surgery were progression of disease (n=13) and patient choice (n=9). There was 1 postoperative surgical death. The median PFS and OS for the whole cohort were 7.1 (95% CI, 6.0-9.2) and 22.7 (95% CI, 14.3-not estimable) months, respectively. Patients with MSKCC poor-risk disease or progressive disease prior to surgery had a poor outcome (median OS, 5.7 [95% CI, 2.6-10.8] and 3.9 [95% CI, 0.5-9.1] months, respectively). Surgical complications were observed in 14 (22%) of the nephrectomies. Biomarker analysis from sequential tissue samples revealed a decrease in CD8 expression (20.00 vs 13.75; P=.05) and significant reduction in expression of von Hippel–Lindau tumor suppressor (100 vs 40; PConclusions and RelevanceNephrectomy after upfront pazopanib therapy could be performed safely and was associated with good outcomes in patients with intermediate-risk metastatic clear cell renal cancer.
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.